A Pilot RCT to Improve Cognitive Processing Speed in Acute SCI
Launched by KESSLER FOUNDATION · Feb 1, 2024
Trial Information
Current as of July 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking to see if a special cognitive training program can help improve how quickly people with recent spinal cord injuries (SCI) can process information. The study is specifically focused on individuals who are about six months post-injury and are between the ages of 18 to 59. It aims to help those who may be experiencing difficulties with thinking and processing speed following their injury.
If you or someone you know has had a recent traumatic spinal cord injury and fits the age criteria, you may be eligible to participate. Participants in this study can expect to engage in activities designed to boost their cognitive skills. It's important to note that those with other major neurological issues, psychiatric conditions, or significant vision problems will not be able to join. The trial is currently recruiting participants, and it offers an opportunity to contribute to research that could help improve the lives of others facing similar challenges.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18-59 years old
- • recent traumatic SCI (approximately 6 months post-injury)
- Exclusion Criteria:
- • no other significant neurological, psychiatric or substance use history
- • no significantly impairing visual disturbance
About Kessler Foundation
Kessler Foundation is a leading nonprofit organization dedicated to advanced rehabilitation research and the development of innovative strategies to improve the lives of individuals with disabilities. With a strong emphasis on clinical trials and evidence-based practices, the Foundation collaborates with academic institutions, healthcare providers, and industry partners to explore novel therapeutic approaches and technologies. Its commitment to enhancing mobility, cognitive function, and overall quality of life for people with neurological and musculoskeletal conditions drives its mission to transform rehabilitation outcomes through cutting-edge research and community engagement.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seattle, Washington, United States
Seattle, Washington, United States
Englewood, Colorado, United States
East Hanover, New Jersey, United States
Patients applied
Trial Officials
Erica Weber, PhD
Principal Investigator
Kessler Foundation
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported